Chronic lymphocytic leukemiaFlow cytometryImmunophenotypeMinimal residual diseaseFlow-cytometric demonstration of the typical chronic lymphocytic leukemia (CLL) immunophenotype is vital for diagnosis. CLL has a characteristic immunophenotype, expressing CD5, CD19, dim CD20, dim CD22, CD23, bright CD43, ...
to date, no method has been available to identify and quantify BCR-ABL1-positive cells using flow cytometry, at least to our knowledge. The present approach combines the advantage of flow cytometry with specific and sensitive detection of the BCR-...
Hartmann E, Rudiger T, Jaffe ES, Muller-Hermelink HK, Ott G, Fend F, Rosenwald A (2007) IgVH mutational status and clonality analysis of Richter’s transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 ...
Flow Cytometry 来自 Wiley 喜欢 0 阅读量: 8 作者: CM Yuan 出版社: John Wiley & Sons, Ltd 摘要: Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is a neoplasm of mature B lymphocytes involving peripheral blood (PB), bone marrow (BM), spleen, and lymph nodes (LN). CLL ...
Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method. BACKGROUND: Flow cytometry allows specific assessment of the expression of ZAP-70, a promising new prognostic factor in B-cell chronic lymphocytic leukemia... N Gac...
Flow CytometryCell DifferentiationLeukemia, Lymphocytic, Chronic, B-CellTelomerase is a telomere-specific consisting of and RNA components, which is activated in germline and the majority of and serves to counter the consequences of telomere shortening. The component, hTERT, is believed to be the ...
Cytometry Part B: Clinical Cytometry , n/a-n/a /Sergey N.Preobrazhensky, PhilippeSzankasi, David W.Bahler. (2011) Improved flow cytometric detection of ZAP-70 in chronic lymphocytic leukemia using experimentally optimized isotypic control antibodies. Cytometry Part B: Clinical Cytometry , n/a...
The common B-chronic lymphocytic leukemia (B-CLL) antigen (cCLLa) appears to be ideal for targeted immunotherapy in that it is the most prevalent and disease-restricted marker in B-CLL. To assess this potential, we developed four immunot... GB Faguet,JF Agee - 《Blood》 被引量: 38发表...
3608Chronic lymphocytic leukemia (CLL) is an indolent disease with largely heterogeneous clinical course. While the diagnosis is made based on the characteristic immunophenotype as determined by multiparameter flow cytometry (MFC) anothe... W Kern,S Schnittger,F Dicker,... - 《Blood》 被引量: ...
Hairy cell leukemia is a mature B cell neoplasm. It is usually classified as a sub-type of chronic lymphoid leukemia (CLL) for convenience. It is uncommon, representing about 2% of all leukemias, or less than a total of 2000 new cases diagnosed each year in North America and Western Europ...